Company news
EMV Capital PLC news in 2015
EMV Capital PLC's news releases, calls and decks from 2015, newest first.
Lawrence Cohen appointed as CEO of Glycotest Inc.
December 16, 2015
Appointment of Gene Walther as Vortex CEO
December 14, 2015
ProAxsis' ProteaseTagT research update
December 3, 2015
ProAxsis presents data to validate its immunoassay
November 30, 2015
Grant of Options
November 10, 2015
Result of Placing and Further Allotment of Shares
November 6, 2015
Proposed Placing and Fund Raising to raise c.£20m
October 1, 2015
Divestment of Shareholding in Frontier BioSciences
September 18, 2015
Vortex BioSciences granted critical patent
September 15, 2015
Steve Curd appointed as CEO of Wanda
September 9, 2015
Divestment of non-core assets to align portfolio
August 7, 2015
ProAxsis launches first-in-class ProteaseTag test
August 4, 2015
Key patent granted for Glucosense's technology
July 15, 2015
Results of Annual General Meeting
June 22, 2015
Notification of Major Interest in Shares
June 5, 2015
PDS Biotechnology reports positive Phase I results
May 28, 2015
Capital Markets Day
May 15, 2015
Dr. François R. Martelet appointed as CEO
May 11, 2015
NetScientific invests in Neumitra
May 7, 2015
NetScientific Forms New Digital Health Company
May 1, 2015
NetScientific Capital Markets Day
April 29, 2015
Significant Progress in core Portfolio Companies
March 24, 2015
Notice of Full Year Results
March 20, 2015
Appointment of Non-Executive Director
February 26, 2015
NetScientific teams up with KU Leuven
January 7, 2015